Related Experiment Videos
A computational phenotype for pediatric asthma exacerbations requiring hospitalization using electronic health record
Colin Rogerson1,2, Danielle Severns1, Jason Stemple1
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 46202, United States.
Insights
We developed a computational phenotype to accurately identify pediatric asthma exacerbations requiring hospitalization using electronic health records. This tool improves patient selection for research studies.
Area of Science:
- Pediatric Pulmonology
- Health Informatics
- Clinical Epidemiology
Background:
- Computational phenotypes enhance patient selection for observational studies.
- Accurate identification of pediatric asthma exacerbations is crucial for research.
Purpose of the Study:
- To derive and validate a computational phenotype for pediatric asthma exacerbation requiring hospitalization.
- To improve the accuracy of identifying relevant patient cohorts from electronic health records.
Main Methods:
- Retrospective cohort study utilizing electronic health record (EHR) data.
- Iterative development and refinement of phenotype criteria based on diagnostic codes and medication data.
- Validation of positive predictive value (PPV) through manual chart review and sensitivity analysis against an established database.
Main Results:
- The final computational phenotype achieved a 93% positive predictive value (PPV) for pediatric asthma exacerbation requiring hospitalization.
- Compared to using only diagnostic codes (34% PPV), the developed phenotype significantly improved accuracy.
- The phenotype demonstrated high sensitivity (97%) when applied to a critical care cohort.
Conclusions:
- A validated computational phenotype using EHR data can effectively identify pediatric asthma exacerbations needing hospitalization.
- This phenotype offers a valuable tool for future observational studies in pediatric asthma.
- Potential need for institution-specific adjustments to the phenotype for optimal performance.
Background:
Computational phenotypes can be used to improve patient selection for observational studies. We sought to derive and validate a computational phenotype for pediatric asthma exacerbation requiring hospitalization.
Methods:
Retrospective cohort study using electronic health record (EHR) data from a single quaternary children's hospital. We used ICD 9 and 10 diagnostic codes and medication data to develop multiple iterations of a computational phenotype. Encounters identified by each phenotype were manually reviewed by expert chart reviewers, and positive predictive value (PPV) was calculated. Sensitivity was obtained by comparison with an established cohort in the Virtual Pediatric Systems (VPS) database.
Measurements And Main Results:
Our cohort included 19 015 pediatric encounters from 2014 to 2022 admitted with an indication of asthma. Starting with 3 broad criteria (a diagnostic code for asthma, receipt of albuterol, and receipt of systemic steroids), we iteratively added phenotype criteria to improve the PPV. The initial phenotype using albuterol and systemic steroids had 65% PPV. Restricting the timeframe for receipt to the first 24 h of the encounter and increasing the amount of albuterol used improved the PPV to 85%. Encounters using only dexamethasone or not having a diagnostic code for asthma were tested and found to have low PPV. The final phenotype included the use of >1 nebulized albuterol treatment or continuous albuterol and the use of systemic steroids in the first 24 h of hospitalization, plus a diagnostic code for asthma, and excluded encounters that only used dexamethasone. This phenotype achieved a PPV of 93%. Using this as a reference metric, defining the cohort based only on diagnostic codes had a PPV of 34%. Applying these criteria to the VPS cohort admitted to the intensive care unit yielded a sensitivity of 97%.
Conclusions:
We created a computational phenotype for pediatric asthma exacerbation requiring hospitalization using structured EHR data elements, which achieved a high positive predictive value and sensitivity. This phenotype can be leveraged for future observational studies in this population, but may require institution-specific adjustments.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma-I: Introduction